A detailed history of Northern Trust Corp transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 219,174 shares of MEDP stock, worth $76.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
219,174
Previous 216,034 1.45%
Holding current value
$76.4 Million
Previous $89 Million 17.85%
% of portfolio
0.01%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$320.58 - $457.29 $1.01 Million - $1.44 Million
3,140 Added 1.45%
219,174 $73.1 Million
Q2 2024

Aug 14, 2024

BUY
$372.0 - $424.34 $6.99 Million - $7.97 Million
18,790 Added 9.53%
216,034 $89 Million
Q1 2024

May 14, 2024

SELL
$284.87 - $413.31 $8.51 Million - $12.4 Million
-29,885 Reduced 13.16%
197,244 $79.7 Million
Q4 2023

Feb 13, 2024

SELL
$227.52 - $312.68 $3.2 Million - $4.4 Million
-14,073 Reduced 5.83%
227,129 $69.6 Million
Q3 2023

Nov 13, 2023

BUY
$233.98 - $281.67 $2.15 Million - $2.59 Million
9,192 Added 3.96%
241,202 $58.4 Million
Q2 2023

Aug 11, 2023

SELL
$187.26 - $240.17 $23.1 Million - $29.6 Million
-123,216 Reduced 34.69%
232,010 $55.7 Million
Q1 2023

May 15, 2023

BUY
$174.31 - $239.52 $230,263 - $316,405
1,321 Added 0.37%
355,226 $66.8 Million
Q4 2022

Feb 13, 2023

SELL
$153.06 - $226.57 $183,978 - $272,337
-1,202 Reduced 0.34%
353,905 $75.2 Million
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $4.32 Million - $5.43 Million
-29,770 Reduced 7.73%
355,107 $55.8 Million
Q2 2022

Aug 12, 2022

SELL
$130.2 - $168.03 $2.83 Million - $3.65 Million
-21,724 Reduced 5.34%
384,877 $57.6 Million
Q1 2022

May 13, 2022

SELL
$138.87 - $214.31 $2.85 Million - $4.39 Million
-20,494 Reduced 4.8%
406,601 $66.5 Million
Q4 2021

Feb 08, 2022

SELL
$182.74 - $227.9 $1.6 Million - $2 Million
-8,777 Reduced 2.01%
427,095 $93 Million
Q3 2021

Nov 15, 2021

SELL
$170.18 - $198.21 $1.16 Million - $1.35 Million
-6,793 Reduced 1.53%
435,872 $82.5 Million
Q2 2021

Aug 13, 2021

SELL
$158.62 - $194.3 $446,991 - $547,537
-2,818 Reduced 0.63%
442,665 $78.2 Million
Q1 2021

May 12, 2021

BUY
$132.02 - $168.26 $2.33 Million - $2.97 Million
17,634 Added 4.12%
445,483 $73.1 Million
Q4 2020

Feb 11, 2021

SELL
$109.38 - $149.19 $740,502 - $1.01 Million
-6,770 Reduced 1.56%
427,849 $59.6 Million
Q3 2020

Nov 16, 2020

BUY
$92.95 - $130.61 $5.01 Million - $7.03 Million
53,849 Added 14.14%
434,619 $48.6 Million
Q2 2020

Aug 14, 2020

BUY
$68.08 - $95.68 $1.01 Million - $1.42 Million
14,833 Added 4.05%
380,770 $35.4 Million
Q1 2020

May 14, 2020

BUY
$61.71 - $101.95 $283,063 - $467,644
4,587 Added 1.27%
365,937 $26.9 Million
Q4 2019

Feb 14, 2020

SELL
$70.08 - $84.64 $602,968 - $728,242
-8,604 Reduced 2.33%
361,350 $30.4 Million
Q3 2019

Nov 13, 2019

BUY
$62.38 - $85.89 $3.82 Million - $5.26 Million
61,257 Added 19.84%
369,954 $31.1 Million
Q2 2019

Aug 13, 2019

BUY
$53.64 - $65.42 $773,864 - $943,814
14,427 Added 4.9%
308,697 $20.2 Million
Q1 2019

May 13, 2019

BUY
$49.38 - $70.58 $211,642 - $302,505
4,286 Added 1.48%
294,270 $17.4 Million
Q4 2018

Feb 12, 2019

BUY
$46.97 - $63.98 $253,215 - $344,916
5,391 Added 1.89%
289,984 $15.3 Million
Q3 2018

Nov 14, 2018

BUY
$43.25 - $63.74 $4.35 Million - $6.41 Million
100,548 Added 54.63%
284,593 $17.1 Million
Q2 2018

Sep 18, 2018

SELL
$34.03 - $45.46 $78,711 - $105,148
-2,313 Reduced 1.24%
184,045 $7.91 Million
Q2 2018

Aug 14, 2018

BUY
$34.03 - $45.46 $1.39 Million - $1.85 Million
40,786 Added 28.02%
186,358 $8.01 Million
Q1 2018

May 09, 2018

BUY
$32.03 - $39.05 $747,388 - $911,192
23,334 Added 19.09%
145,572 $5.08 Million
Q4 2017

Feb 14, 2018

BUY
$32.46 - $38.31 $191,351 - $225,837
5,895 Added 5.07%
122,238 $4.43 Million
Q3 2017

Nov 13, 2017

BUY
$27.43 - $33.11 $3.19 Million - $3.85 Million
116,343
116,343 $3.71 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.